AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $205.01, giving the company a market capitalization of 319.54B. It carries a P/E multiple of 31.16 and pays a dividend yield of 1.5%.
On 2026-02-15, AstraZeneca(AZN) stock traded between a low of $203.98 and a high of $206.71. Shares are currently priced at $205.01, which is +0.5% above the low and -0.8% below the high.
AstraZeneca(AZN) shares are trading with a volume of 2.5M, against a daily average of 2.49M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $206.71 and a 52-week low of $122.48.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $206.71 and a 52-week low of $122.48.
AZN News
Full results from the Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s (AZN) Breztri Aerosphere demonstrated s...
AstraZeneca plc ((GB:AZN)) has held its Q4 earnings call. Read on for the main highlights of the call. Valentine's Day Sale - 70% Off Unlock hedge fund-level da...
AstraZeneca Plc (NASDAQ:AZN) on Tuesday reported fourth-quarter 2025 sales of $15.50 billion, up 4% year over year (+2% at constant currency or cc), almost in l...
Analyst ratings
80%
of 30 ratingsMore AZN News
Technology AstraZeneca Leans On Its Cancer Division For A Fourth-Quarter Beat Licensing AstraZeneca (AZN) stock creeped higher early Tuesday after the pharma gi...
Reports Q4 revenue $14.54B, consensus $14.53B. Pascal Soriot, CEO, AstraZeneca (AZN), commenting on the results said: “In 2025 we saw strong commercial performa...
Chief Executive Officer Pascal Soriot said AstraZeneca's pipeline momentum will continue into 2026. Dado Ruvic/Reuters AstraZeneca AZN -1.53 %decrease; red dow...
AstraZeneca on Tuesday announced fourth-quarter profit in line with expectations on demand for its cancer and heart drugs. The pharmaceutical company AZN UK:AZ...
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.